AIMT
Hudson Bay Capital Management’s Aimmune Therapeutics, Inc. AIMT Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q4 | – | Sell |
-116,700
| Closed | -$4.02M | – | 845 |
|
|
2020
Q3 | $4.02M | Sell |
116,700
-553,300
| -83% | -$19.1M | 0.06% | 252 |
|
|
2020
Q2 | $11.2M | Sell |
670,000
-15,716
| -2% | -$263K | 0.2% | 79 |
|
|
2020
Q1 | $9.89M | Buy |
685,716
+410,716
| +149% | +$5.92M | 0.25% | 70 |
|
|
2019
Q4 | $9.2M | Sell |
275,000
-165,000
| -38% | -$5.52M | 0.21% | 85 |
|
|
2019
Q3 | $9.21M | Sell |
440,000
-10,000
| -2% | -$209K | 0.25% | 76 |
|
|
2019
Q2 | $9.37M | Buy |
450,000
+154,900
| +52% | +$3.23M | 0.22% | 82 |
|
|
2019
Q1 | $6.6M | Buy |
295,100
+50,100
| +20% | +$1.12M | 0.09% | 119 |
|
|
2018
Q4 | $5.86M | Buy |
245,000
+95,000
| +63% | +$2.27M | 0.08% | 128 |
|
|
2018
Q3 | $4.09M | Hold |
150,000
| – | – | 0.05% | 193 |
|
|
2018
Q2 | $4.03M | Sell |
150,000
-10,000
| -6% | -$269K | 0.06% | 180 |
|
|
2018
Q1 | $5.09M | Buy |
160,000
+140,000
| +700% | +$4.46M | 0.11% | 122 |
|
|
2017
Q4 | $756K | Sell |
20,000
-50,000
| -71% | -$1.89M | 0.02% | 289 |
|
|
2017
Q3 | $1.74M | Sell |
70,000
-90,000
| -56% | -$2.23M | 0.04% | 202 |
|
|
2017
Q2 | $3.29M | Buy |
+160,000
| New | +$3.29M | 0.07% | 154 |
|